Skip to content

Effect of Rala Sarshapa Dhoopana in the Management of Bleeding Hemorrhoids A Controlled Clinical Study

A CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFECT OF RALA SARSHAPA DHOOPANA IN THE MANAGEMENT OF RAKTARSH W.S.R. TO BLEEDING HAEMORRHOIDS. - Nil

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106138
Enrollment
66
Registered
2026-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K929- Disease of digestive system, unspecified

Interventions

None listed

Sponsors

Dr Swarnima Nilesh Kucheriya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of bleeding Internal hemorrhoids.(2nd and 3rd Degree) Age 20 60 years of either sex Patients with Hb more than 10mg/dl in male and more than 8mg/dl in females Patients willing to consent and comply Fit for local Dhoopana procedure

Exclusion criteria

Exclusion criteria: Non-bleeding or thrombosed haemorrhoids. Other associated conditions like Fistula, fissure, carcinoma Severe anaemia Pregnant/lactating women. Malignancies or bleeding due to systemic causes Chronic bleeding disorders. Uncontrolled diabetes or hypertension Known allergy to ingredients (Rala or Sarshapa Taila) Known patients with Asthma or COPD

Design outcomes

Primary

MeasureTime frame
To assess the effect of Rala Sarshapa Dhoopana in reducing per rectal bleeding in patients with bleeding haemorrhoidsTimepoint: 0th day, 4th day, 7th day

Secondary

MeasureTime frame
1. To assess the effect of Rala Sarshapa Dhoopana in associated symptoms like pain and inflammation. 2. To observe time taken for cessation of bleeding in both intervention groups.Timepoint: 0th day, 4th day, 7th day

Countries

India

Contacts

Public ContactDr Swarnima Nilesh Kucheriya

DR G D POL FOUNDATION, YMT Ayurvedic Medical College And Hospital

vtangde@gmail.com9920798297

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026